Mesa 3 | El paciente de #Mieloma Múltiple en Recaída | Jornada de Hospitales de Madrid.

In this conference organized by the Spanish Community of Multiple Myeloma Patients (CEMMP), specialists from 13 Madrid hospitals address, in a clear and accessible way, key aspects of interest to patients with multiple myeloma. The third panel, focused on the patient in relapse, addresses how therapeutic decisions are made when the disease recurs, what it means to be a refractory patient, and what the latest advances are in immunotherapy, bispecific antibodies, and CAR-T cell therapies. During the session, they also explain when to start treatment in a relapse, how each case is individualized, and what options currently exist for patients with relapsed myeloma. ✅ Differences between biochemical and clinical relapse. ✅ How to decide when to start a new treatment. ✅ What it means to be a refractory patient. ✅ New therapeutic options in relapse. ✅ Conjugated antibodies and bispecific antibodies. ✅ CAR-T cell therapies and how they work. ✅ Individualizing treatments for each patient. ✅ New advances in immunotherapy for multiple myeloma. Participants: 🔴 Dr. María Jesús Blanchard (moderator). Hematologist at the Hematology Department of the Ramón y Cajal University Hospital in Madrid. 🔴 Dr. Jesús San Miguel (co-moderator). Senior Consultant at the Cancer Center of the Clínica Universidad de Navarra (CCUN). 🔴 Dr. Rafael Alonso. Hematologist at the Hematology Department of the 12 de Octubre University Hospital in Madrid. 🔴 Dr. Teresa de Soto. Hematologist at the Hematology Department of the La Paz University Hospital. Gold Sponsorship: · GSK · Johnson & Johnson · Sanofi Bronze Sponsorship: · Bristol Myers Squibb · Menarini Group · Stemline (A Menarini Group Company) · Oncopeptides Endorsed by: · SEHH (Spanish Society of Hematology and Hemotherapy) · SEHH Social --------------------------------------------------------------------- 🔴 Subscribe to our YouTube channel. CEMMP | Spanish Community of Multiple Myeloma Patients We are a nationwide association dedicated exclusively to multiple myeloma. We inform and support patients and their families living with the disease, providing content designed for patients and based on medical evidence. On this channel you'll find: ✔️ Informative sessions for patients ✔️ Presentations by hematology specialists ✔️ Easy-to-understand medical information ✔️ Interviews and podcasts ✔️ Resources for myeloma follow-up 📪 Newsletter ➡️ https://bit.ly/3Wrjnmn 🎙️ Podcast ➡️ https://bit.ly/3WqLsKf 🗣️ Support group ➡️ https://bit.ly/3zo2pLS Follow us on social media: Facebook:   / comunidadmielomamultiple   Twitter:   / cemmp_mieloma   Instagram:   / cemmp.mielomamultiple   LinkedIn:   / cemmp   🌐 Official website: https://www.comunidadmielomamultiple.com